MDHP3G-Malate dehydrogenase

Added to your cart

MDHP3G-Malate dehydrogenase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU MDHP3G

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

In Clinical Chemistry Malate Dehydrogenase has the following applications: + Determination of CO2/bicarbonate in biological fluids in conjunction with Pep-Carboxylase + Indicator enzyme for the determination of serum GOT (Glutamic Oxaloacetic Transaminase)/AST (Aspartate transaminase) which is an indicator of liver function + To determine metabolites e.g. Oxaloacetate and Malate
MDHP3G

More information

Attributes

Description

  • Abbreviations
  • MDH
  • Associated Activity
  • CK: less than 0.001% GPT: less than 0.0025% LDH: less than 0.001% GOT: less than 0.0025% Fumerase: less than 0.001% GLDH: less than 0.0025%
  • Lead Time
  • 10 weeks
  • Storage
  • Store at +2°C to +8°C. DO NOT FREEZE.
  • Shelf Life
  • 6 months
  • Source
  • Porcine heart
  • Activity
  • ≥1500U/mg protein
  • Systematic Name
  • (S)-Malate:NAD+ oxidoreductase
  • Unit Definition
  • That amount of enzyme causing the oxidation of one micromole of NADH per minute at 25C and pH 7.4
  • Form
  • An Ammonium sulphate-free solution in 50% Glycerol

Technical Documents

Product Specification (55.52KB)

Analytical Procedures (128.03KB)

Product Information (298.74KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox